An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis.
randomized
EVIDENCE COMPARISON
SupportiveKetoconazole
vs Pimecrolimus
for Redness Reduction
Limited evidence suggests ketoconazole and pimecrolimus perform equally for reducing redness and improving skin tone.
1.00x
Effect ratio
Neither
Favored
1
Study
Direct
Comparison
CoreSubjective endpointTone
Limits: Includes subjective endpoint
How to read this claim
Direct comparison with enough study context for public-facing comparative wording, with limits noted for includes subjective endpoint.
The published evidence does not currently show a major generalization warning beyond the listed study limits.